Literature DB >> 17047196

Population-based assessment of the surgical management of locally advanced colorectal cancer.

Anand Govindarajan1, Natalie G Coburn, Alex Kiss, Linda Rabeneck, Andrew J Smith, Calvin H L Law.   

Abstract

BACKGROUND: Evidence-based guidelines recommend multivisceral resection for patients with locally advanced adherent colorectal cancer because it reduces local recurrence and improves survival. However, this procedure can increase morbidity compared with standard resection and may not be practiced uniformly. We performed a population-based study to examine surgical practice and outcomes among patients with locally advanced adherent colorectal cancer in the United States.
METHODS: Patients who were 18 years or older and who had surgical resection for nonmetastatic, locally advanced adherent colorectal cancer from January 1, 1988, through December 31, 2002, were identified from the Surveillance, Epidemiology, and End Results (SEER) registry. Logistic regression was used to examine patient, tumor, and geographic factors associated with multivisceral resection. Cumulative early mortality (i.e., at 1 and 6 months after diagnosis) and 5-year survival were obtained from Kaplan-Meier estimates; adjusted risks of death were calculated using Cox proportional hazards models. All statistical tests were two-sided.
RESULTS: We identified 8380 patients who underwent surgical resection for locally advanced adherent colorectal cancer, of whom 33.3% were managed with multivisceral resection. Among colon cancer patients, younger age at diagnosis, female sex, SEER region, node negativity, and left-sided tumors were independently associated with having had a multivisceral resection. Among rectal cancer patients, younger age at diagnosis and female sex were positively and statistically significantly associated with multivisceral resection, whereas receipt of neoadjuvant radiation was inversely and statistically significantly associated with multivisceral resection. Compared with standard resection, multivisceral resection was associated with improved overall survival for patients with colon (hazard ratio [HR] = 0.89, 95% confidence interval [CI] = 0.83 to 0.96) and rectal (HR = 0.81, 95% CI = 0.70 to 0.94) cancer, with no associated increase in early mortality.
CONCLUSIONS: The majority of patients with locally advanced colorectal cancer did not receive a multivisceral resection. The geographic variation in the application of this procedure in patients with colon cancer suggests that local organizational structures and processes of care may play an important role in patient treatment and, therefore, prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 17047196     DOI: 10.1093/jnci/djj396

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  29 in total

1.  Risk factors and outcomes for anastomotic leakage in colorectal surgery: a single-institution analysis of 1576 patients.

Authors:  Mark A Boccola; Petra G Buettner; Warren M Rozen; Simon K Siu; Andrew R L Stevenson; Russell Stitz; Yik-Hong Ho
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 2.  Sex-specific aspects of tumor therapy.

Authors:  Kerstin Borgmann; Ekkehard Dikomey; Cordula Petersen; Petra Feyer; Ulrike Hoeller
Journal:  Radiat Environ Biophys       Date:  2009-02-26       Impact factor: 1.925

3.  Right and Transverse Colonic Multi-Visceral Resections for Locally Advanced Cancers-a Single-Center Experience.

Authors:  Joseph Sebastian; Mohamed Boshnaq; Mohanraj Harilingam; Chukwuemeka Anele; Mansoor Akhtar; Deya Marzouk
Journal:  Indian J Surg Oncol       Date:  2018-04-20

4.  Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.

Authors:  Koh Ye Xin; Deanna Wan Jie Ng; Grace Hwei Ching Tan; Melissa Ching Ching Teo
Journal:  J Gastrointest Cancer       Date:  2014-09

5.  Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer?

Authors:  Lian-Ming Wu; Jiong Zhu; Jiani Hu; Yan Yin; Hai-Yan Gu; Jia Hua; Jie Chen; Jian-Rong Xu
Journal:  Int J Colorectal Dis       Date:  2013-03-21       Impact factor: 2.571

Review 6.  Safety in the operating theatre--a transition to systems-based care.

Authors:  Thomas G Weiser; Michael P Porter; Ronald V Maier
Journal:  Nat Rev Urol       Date:  2013-02-19       Impact factor: 14.432

7.  Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer.

Authors:  George Z Li; Ryan S Turley; Michael E Lidsky; Andrew S Barbas; Srinevas K Reddy; Bryan M Clary
Journal:  J Gastrointest Surg       Date:  2012-06-28       Impact factor: 3.452

8.  Neoadjuvant Radiation Therapy in Locally Advanced Colon Cancer: a Cohort Analysis.

Authors:  Devi Mukkai Krishnamurty; Alexander T Hawkins; Katerina O Wells; Matthew G Mutch; Mathew L Silviera; Sean C Glasgow; Steven R Hunt; Sekhar Dharmarajan
Journal:  J Gastrointest Surg       Date:  2018-02-09       Impact factor: 3.452

9.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

10.  The Impact of a Multivisceral Resection and Adjuvant Therapy in Locally Advanced Colon Cancer.

Authors:  Lieve G J Leijssen; Anne M Dinaux; R Amri; Hiroko Kunitake; Liliana G Bordeianou; David L Berger
Journal:  J Gastrointest Surg       Date:  2018-10-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.